Dergiler / Erciyes Medical Journal / 2017 / Cilt: 39 - Sayı: 3

Case of Neuroacanthocytosis Course With Neuropathy, Epilepsy and Choreiform Movement Disorder

Sayfa
62–64
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

In this article, a 38-year-old male case featuring both common and rare clinical reflections of neuroacanthocytosis is presented.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Neuroacanthocytosis is a neurodegenerative disease characterized by movement disorders, seizures, dementia, and behavioral changes, as well as spiked acanthocytes in peripheral smears, but it is rarely accompanied by axonal neuropathy.
📊
Temel Bulgular & Veri:Chorea-acanthocytosis is an autosomal recessive, progressive disease, for which the neurological symptoms start in the 20s.
💡
Sonuç & Katkı:In this article, a 38-year-old male case featuring both common and rare clinical reflections of neuroacanthocytosis is presented.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Neuroacanthocytosis is a neurodegenerative disease characterized by movement disorders, seizures, dementia, and behavioral changes, as well as spiked acanthocytes in peripheral smears, but it is rarely accompanied by axonal neuropathy. Before making a definitive diagnosis of neuroacanthocytosis, diseases like Huntington disease, Parkinson disease, Tourette syndrome, and Wilson disease should first be considered. Diagnosis is essentially based on the clinical picture and the presence of acanthocytes in peripheral blood. Its treatment is symptomatic, and therefore treatment measures may vary from case to case. Drugs such as anticholinergics, antipsychotics, and antiepileptics are typically used for the treatment of the symptoms. Chorea-acanthocytosis is an autosomal recessive, progressive disease, for which the neurological symptoms start in the 20s. The onset symptoms are generally mild cognitive or psychiatric disorders and these complaints are observed before the neurological findings appear. In some patients, epileptic seizures may occur before the movement disorders. In this article, a 38-year-old male case featuring both common and rare clinical reflections of neuroacanthocytosis is presented.

🔖

Bu Makaleye Atıf Yap

SÖNMEZ, A., GÖL, M. F., ERDOĞAN, F. F., NEUROPATHY, C. W. (2017). Case of Neuroacanthocytosis Course With Neuropathy, Epilepsy and Choreiform Movement Disorder. Erciyes Medical Journal, Cilt: 39 - Sayı: 3, 62–64. https://ajindex.com/articles/223477

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (1)

  1. Lossos A, Dobson-Stone C, Monaco AP, Soffer D, Rahamim E, Newman JP, et al. Early clinical heterogeneity in choreoacanthocytosis. Arch Neurol 2005; 62(4): 611-4. [CrossRef] 2. Rubio JP, Danek A, Stone C, Chalmers R, Wood N, Verellen C, et al. Chorea-acanthocytosis: genetic linkage to chromosome 9q21. Am J Hum Genet 1997; 61(4): 899-908. [CrossRef] 3. Walker RH, Morgello S, Davidoff-Feldman B, Melnick A, Walsh MJ, Shashidharan P, et al. Autosomal dominant chorea-acanthocytosis with polyglutamine-contai-ning neuronal inclusions. Neurology 2002; 58(7): 1031-7. [CrossRef] 4. Hardie RJ, Pulln HW, Harding AE, Owen JS, Pires M, Daniels GI, et al. Neuroacanthocytosis. A clinical, hematological and pathological study of 19 cases. Brain 1991; 14(Pt 1A): 13-49. 5. Yiğiter R, Elçi MA, Hanağası H. Neuroacanthocytosis: A Case Report. Acıbadem Üniversitesi Sağlık Bilimleri Dergisi 2014; 5: 3. 6. Özer F, Özben S. Secondary Parkinsonizm. Emre M Ed. 1st ed, Ankara, Güneş Tıp Kitabevi 2010, pp 255-6. 7. Oğuz E, Özben S, Özer F, Atmaca B, Çetin S. Neuroacanthocytosis: A Case Report. Parkinson Hast Hareket Boz Der 2008; 11(2): 24-8. 8. Al-Asmi A, Jansen AC, Badhwar A, Dubeau F, Tampieri D, Shustik C, et al. Familial temporal lobe epilepsy as a presenting feature of choreoacanthocytosis. Epilepsia 2005; 46(8): 1256-63. [CrossRef] 9. Schneider SA, Lang AE, Moro E, Bader B, Danek A, Bhatia KP. Characteristic head drops and axial extension in advanced choreaacanthocytosis. Mov Disord 2010; 25(10): 1487-91. [CrossRef] 10. Danek A, Rubio JP, Rampoldi L, Ho M, Dobson-Stone C, Tison F. McLeod neuroacanthocytosis: genotype and phenotype. Ann Neurol 2001; 50(6): 755-64. [CrossRef]